Companies › GCTK

Glucotrack Inc (GCTK)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001506983 · EDGAR filings · Updated 2026-07-27

Glucotrack Inc (GCTK) has reported institutional ownership of 8.2%, with 13 institutional managers holding positions valued at $103.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — ARS filed
• 2026-07-17 — Proxy statement (DEF 14A) filed
• 2026-07-15 — 425 filed
• 2026-07-15 — Current report (8-K) filed
• 2026-06-17 — PRE 14A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Glucotrack Inc has 13 institutional holders and institutional ownership of 8.2%.

Insider activity

Insiders reported 10 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

BLUEJAY DIAGNOSTICS INC (BJDX) · Enveric Biosciences Inc (ENVB) · ORAGENICS INC (OGEN) · Catheter Precision Inc (VTAK) · AIM IMMUNOTECH INC (AIM) · Jaguar Health Inc (JAGX)